Heart Disease Trial, Recruiting NCT07077057 Sponsor: Cardiocentro Ticino Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT07077057
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are experiencing symptoms that could suggest a possible heart attack, such as chest pain, shortness of breath, sweating, nausea or vomiting, pain spreading to the shoulder, arm, jaw, or back, unusual tiredness, or feeling lightheaded
  • People who are 18 years of age or older
  • People who are able to give their own informed consent to take part in the trial

Who may not be able to join:

  • People who have already been diagnosed with a specific type of heart attack called an ST-segment elevation MI (STEMI) by the treating doctor
  • People who are pregnant or breastfeeding
  • People who are not legally able to give their own consent to participate
  • People whose symptoms began more than 24 hours before arriving at the clinical setting

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 7 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Cardiocentro Ticino
Registry
ClinicalTrials.gov
Start date
23 August 2025
Est. completion
1 August 2027

Where this trial is recruiting

🇨🇭 Switzerland

Primary endpoints

Hierarchical primary endpoint

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov